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ABSTRACT 
 
Thelper cells are crucial elements of the immune system, and they differentiate into several 
subsets depending on their cytokine environment. Each subset contributes to a certain type 
of immune response by producing its characteristic cytokines. Classification of Thelper cells 
into subsets is a useful conceptual framework to investigate their biological functions. 
However, this classification is a simplification because the subsets are rather a continuum 
than discrete types. A necessary condition for health is the balanced presence and activity 
of the different Thelper subsets. Imbalanced activity of the Thelper subsets contributes to 
several diseases ranging from cancer to autoimmune and inflammatory diseases. 
 
This thesis focuses on studying Thelper subsets that have been previously described as being 
associated with and contributing to autoimmune diseases, for example Multiple Sclerosis. 
Thelper cells producing the cytokines GM-CSF, IFN-g and/or IL-17 have been described to 
be important in the pathogenesis of this disease. The biological aspects studied in this thesis 
include the differentiation, cytokine profiles and gene regulatory patterns of these Thelper 
subsets. From a methodological point of view, this thesis also explores possibilities to 
combine experimental and computational approaches. 
 
Paper I is focused on the (in vitro) differentiation of human GM-CSF producing Thelper cells. 
Herein, various types of stimuli are tested and analyzed in a data driven way. As a main 
result, the cytokine TGF-b is identified as a context dependent modulatory factor that can 
induce or repress the differentiation of human GM-CSF producing Thelper cells depending 
on activation type or sodium chloride concentration. GM-CSF production is highly 
correlated with IFN-g on the single cell level and with FOXP3 on the population level. 
Furthermore, human GM-CSF producing Thelper cells comprise several subpopulations, the 
composition of which is altered by the cytokine environment. 
 
Paper II explores the role of splice isoforms of FOXP3 (the key transcription factor of 
immunosuppressive regulatory T cells) in Crohn’s disease and in the differentiation of 
human inflammatory Thelper cell subsets. This paper identifies a connection between the pro-
inflammatory cytokine IL-1b, FOXP3 alternative splicing, and the differentiation of pro-
inflammatory IL-17 producing Thelper cells. Furthermore, the paper reveals a significant 
correlation between a certain FOXP3 splice isoform and IL-17 expression in affected tissue 
from Crohn’s disease patients. 
 
Paper III presents a web application that allows non-expert users to apply pre-processing 
and advanced statistical methods on single cell cytometry data. The aim of this tool is to 
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Paper III presents a web application that allows non-expert users to apply pre-processing 
and advanced statistical methods on single cell cytometry data. The aim of this tool is to 
make the statistical approach to cytometry data more accessible to wet-lab biologists, and 
therefore serve this unmet need. 
 
Paper IV aims to give an insight and understanding into the gene regulation and the 
connection between chromatin and transcriptional activity in human Thelper cells. Herein, the 
focus is on studying the characteristics of memory and GM-CSF producing Thelper cells. For 
this purpose, chromatin (ATAC-seq) and gene expression (RNA-seq) data are utilized in a 
combined manner and gene regulatory networks, including transcription factors that appear 
to be important for defining memory and GM-CSF producing Thelper cells, are identified. 
These transcription factors might be involved in diseases such as Multiple Sclerosis, and 
they can be potential candidates for future research towards therapeutic goals. 
 
In summary, the thesis aims to contribute to our understanding of human T cell biology that 
is relevant for disease by combining experimental cellular immunology, next generation 
sequencing and computational approaches. 
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1 INTRODUCTION 
 
1.1 T cells in the immune system 
 
The immune system’s main function is to protect the body against foreign structures by 
eliminating those without harming the body’s own structures (referred to as “self”). The 
immune system has two major arms: the innate and the adaptive immune system. The 
innate immune system recognizes general patterns of foreign structures, for example 
common molecules in bacterial cell walls, and responds rapidly to it [reviewed in (Janeway 
and Medzhitov, 2002)]. In contrast, the adaptive immune system (also called acquired 
immune system) has the ability to “adapt” to recognize virtually any new and unique 
structures referred to as antigens, rendering it highly specific for a certain pathogen. Due to 
this initial adaptation to new foreign structures, the adaptive immune system responds slow 
on the first encounter however, it has the ability to form immunological memory which 
ensures a fast and more efficient response on the second encounter with the same antigen. 
 
Lymphocytes, a type of white blood cells (leukocytes), contribute to both innate immunity 
and adaptive immunity. T and B lymphocytes (also referred to as T and B cells) are the 
main cell types mediating the adaptive immune response, either in a cell-mediated way 
(T cells) or by conferring humoral immunity through secretion of antibody proteins 
(B cells) respectively.   
 
The most abundant types of T lymphocytes and those involved in adaptive immunity are 
Thelper (Th) cells and cytotoxic T lymphocytes (CTLs), defined by the expression of the 
cluster of differentiation (CD) molecules, CD4 and CD8 respectively. The main function of 
Thelper cells is to co-ordinate immune responses by “helping” other immune cells, while 
CTLs can directly kill target cells such as virus-infected cells. Additional T lymphocyte 
lineages have been identified that display features of both innate and adaptive immunity; 
these include natural killer T (NKT) cells, mucosal associated invariant T (MAIT) cells and 
gamma delta T cells (γδ T cells), and are not further discussed here.  
 
Almost every individual Th cell and CTL expresses a unique T cell receptor (TCR) 
comprised of a TCRα, a TCRβ, and CD3 chains, which enables them to recognize a 
specific antigen. This large repertoire of unique TCRs is generated during the development 
of T cells in the thymus, in which segments of TCRα and TCRβ chain genes are rearranged 
and those T cells with a functional rearranged TCR are positively selected, unless their 
affinity to self-antigens is too high which results in deletion (negative selection) of these 
potentially autoreactive T cells. The antigen recognized by a TCRα/β T cell is a peptide 
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derived from a protein of a foreign or self structure. The antigenic peptide has to be 
presented to the T cell by other cells, on the surface of which, the peptide is bound to a 
molecular complex called major histocompatibility complex (MHC), and the peptide:MCH 
complex is then recognized by the cognate TCR. There are two main types of MHC 
molecules: MHC class I and MHC class II, and the peptides bound by them are recognized 
by Th cells and CTLs respectively, through binding of the CD8 and CD4 co-receptors to 
MHC class I and class II respectively. Since MHC class I is expressed abundantly on 
virtually any cell type, CD8+ T cells can directly kill any infected cell with its MHC class I 
containing the cognate antigen. In contrast, MHC class II is expressed on so-called antigen 
presenting cells (APCs), including dendritic cells, macrophages and B cells, thus in order 
for CD4+ T cells to recognize the antigen, it needs to be presented to the Th cell by an 
APC, bound to the MHC class II complex. 
 
Antigen recognition provides the T cell (both CD4+ and CD8+ T cell) with a signal; 
however, this is not sufficient to activate the T cell – which is important in order to limit 
self-reactivity to frequently presented self-antigens. Given that a dangerous situation such 
as an infection is associated with the antigen, additional signals are provided to the T cell: 
co-stimulatory molecules of the B7 family that signal to the CD28 molecule on T cells, as 
well as cytokines (Figure 1). Provided that these signals are present, together with the 
cognate antigen, the reactive T cell will enter to a process of clonal expansion and 
differentiation. At this point, naïve Thelper cells can differentiate into several subsets that 
fulfill different functions (see 1.2 below). Once a clone of T cells carried out their tasks 
(killing for CTLs, and cytokine production for Thelper cells) and the infection is cleared, 
most of them die which reduces the size of the clonal T cell population; however, some of 
them develop into long-lived memory Thelper cells. The next time these memory T cells 
recognize their antigen and become activated, they will react faster and act as effector 
memory T cells (Figure 1). 
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Figure 1: Schematic overview of T cell activation and memory formation. 
The phases of T cell activation and memory formation are shown, with the changes in cell population size, 
cell-to-cell interactions and important signaling events indicated. Modified from (Baaten et al., 2012) 
according to the terms of the Creative Commons Attribution Non Commercial License (CC BY-NC 3.0; 
https://creativecommons.org/licenses/by-nc/3.0/). 
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1.2 Thelper cell subsets 
 
Broadly, CD4+ T cells can be classified into “pro-inflammatory” effector Thelper cells 
contributing to an immune response, or “anti-inflammatory” regulatory T cells (Tregs) 
suppressing the immune response by inhibiting conventional T cells and multiple other 
immune cell types. 
 
The major Treg subset consists CD4+ T cells expressing the “lineage-defining” 
transcription factor Forkhead box P3 (FOXP3), which again can be divided into thymus-
derived and peripherally induced Tregs [reviewed in (Benoist and Mathis, 2012)]. Thymic-
derived Tregs mature in the thymus, while induced Tregs can differentiate from naïve T 
cells given certain signals in the periphery (Figure 2). Besides central tolerance mentioned 
above that ensures negative selection of autoreactive T cells during thymic development, 
Tregs form an important part of peripheral tolerance that helps controlling autoreactive T 
cells that escaped negative selection. While this is important to prevent autoimmune 
diseases, on the other hand, Tregs can also contribute to prevention of anti-tumor immune 
responses. In the following, Thelper cells will refer to effector Thelper cells. 
 
The main function of Thelper cells is to co-ordinate immune responses. They do this mostly 
by sending signals to other immune cells (e.g. B cells, CD8+ T cells, macrophages and 
neutrophils) in the form of secreted cytokines. Cytokines are proteins that can be produced 
by many different cell types, and which act on cells expressing the suitable receptor in an 
autocrine, paracrine or endocrine fashion. Most cytokine receptors signal through the JAK-
STAT pathway, with certain members of the signal transducer and activator of transcription 
(STAT) family preferentially mediating the response to certain cytokines [reviewed in 
(Levy and Darnell, 2002)]. The specific combination of cytokines that a Thelper cell produces 
is also referred to as cytokine profile. The cytokine profile of a Thelper cell will depend on 
the “instructions” (cytokines and other signals) it receives from the surroundings, majorly 
from dendritic cells and other immune cells. These signals, in turn, depend on the type of 
invader these cells sensed, i.e. what the immune system has to fight (Figure 2). 
Consequently, there are different types of Thelper cells, generated for a given defense task, 
and they are defined by their cytokine profile, fulfilling different functions. For the major 
“classical” Thelper subsets, there is also a corresponding “lineage-defining” transcription 
factor that regulates the establishment of the given phenotype and cytokine profile (Figure 
2). A crucial factor for the healthy immune system is a balance between the different types 
of Thelper cells. In case a given type is over-represented or over-active, it can lead to 
diseases. 
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The classical subsets of Thelper cells are Th1, Th2, Th17 and Tfh cells (Figure 2). Th1 cells 
take part in defense against intracellular viruses and bacteria, produce the signature 
cytokine interferon-γ (IFN-γ) along with tumor necrosis factor (TNF)-a and interleukin-2 
(IL-2), and express the lineage-defining transcription factor T-bet. Th2 cells take part in 
defense against extracellular parasites and they produce IL-4 (as well as IL-5 and IL-13), 
and they express GATA3. Th17 cells take part in defense against extracellular pathogens, 
such as fungi and bacteria, and they produce IL-17 (as well as IL-21) and express RORγ(t) 
[reviewed in (Romagnani, 2014)]. Tfh (T follicular helper) cells provide help to B cells for 
antibody production and they are mainly located in the follicles. They produce IL-21 but 
they can also produce Th1 and Th2 cytokines, and they express the lineage-defining 
transcription factor Bcl6 [reviewed in (Baumjohann and Ansel, 2014; Crotty, 2014)]. 
 
 
 
 
Figure 2: A simplified view of the major subsets of CD4+ Thelper cells. 
Naïve CD4+ T cells (depicted in grey) can differentiate into different subsets, when stimulated via the TCR in 
the presence of co-stimulation. The major subsets are the pro-inflammatory effector subsets Th1, Th2, Th17, 
Tfh (white) as well as anti-inflammatory Tregs (yellow). Inducing cytokines or other signals are given in grey. 
Inducing cytokines in parentheses were found to be necessary only in some of the studies, and/or differ 
between mouse and human. The “master transcription factor” for each subset is given in red, and the major 
STAT family members downstream of cytokine signaling receptors in blue. The major cytokines produced by 
each subset are indicated in black. In the healthy state, each effector subset contributes to the defense of 
certain types of pathogens, while Tregs inhibit the immune response and hence prevent autoimmune disease 
and excessive inflammation. Over-activity of the different subsets, on the contrary, can contribute to diseases 
such as allergy and autoimmune disease, as indicated. 
pTreg
IFN-γ
IL-2
IL-4
IL-5    
IL-13
IL-17A
IL-17F
IL-22 
FOXP3
GATA3
Tbet
RORγt
TGF-β + IL-2
IL-2 + IL-4
IFN-γ + IL-12
IL-6 + IL-1β
(+ IL-21 / TGF-β)Naïve
CD4
Th1
Th2
Th17
Tfh
Bcl6
Main cytokines
produced
Health: 
Defending against
Disease:  
Contributing to
IL-21 + ICOS
(+ IL-6 / IL-12 / TGF-β) pathogens
neutralized
by antibodies
IL-21 
IL-4
autoimmune 
disease; 
allergy
intracellular
pathogens
(bacteria, virus)
extracellular
pathogens
(parasites)
extracellular
pathogens
(fungi, bacteria)
autoimmunity;
excessive
inflammation
autoimmune 
disease
autoimmune 
disease
allergy
cancer
STAT1/4
STAT5/6
STAT3
STAT3
STAT5
 
 5 
The classical subsets of Thelper cells are Th1, Th2, Th17 and Tfh cells (Figure 2). Th1 cells 
take part in defense against intracellular viruses and bacteria, produce the signature 
cytokine interferon-γ (IFN-γ) along with tumor necrosis factor (TNF)-a and interleukin-2 
(IL-2), and express the lineage-defining transcription factor T-bet. Th2 cells take part in 
defense against extracellular parasites and they produce IL-4 (as well as IL-5 and IL-13), 
and they express GATA3. Th17 cells take part in defense against extracellular pathogens, 
such as fungi and bacteria, and they produce IL-17 (as well as IL-21) and express RORγ(t) 
[reviewed in (Romagnani, 2014)]. Tfh (T follicular helper) cells provide help to B cells for 
antibody production and they are mainly located in the follicles. They produce IL-21 but 
they can also produce Th1 and Th2 cytokines, and they express the lineage-defining 
transcription factor Bcl6 [reviewed in (Baumjohann and Ansel, 2014; Crotty, 2014)]. 
 
 
 
 
Figure 2: A simplified view of the major subsets of CD4+ Thelper cells. 
Naïve CD4+ T cells (depicted in grey) can differentiate into different subsets, when stimulated via the TCR in 
the presence of co-stimulation. The major subsets are the pro-inflammatory effector subsets Th1, Th2, Th17, 
Tfh (white) as well as anti-inflammatory Tregs (yellow). Inducing cytokines or other signals are given in grey. 
Inducing cytokines in parentheses were found to be necessary only in some of the studies, and/or differ 
between mouse and human. The “master transcription factor” for each subset is given in red, and the major 
STAT family members downstream of cytokine signaling receptors in blue. The major cytokines produced by 
each subset are indicated in black. In the healthy state, each effector subset contributes to the defense of 
certain types of pathogens, while Tregs inhibit the immune response and hence prevent autoimmune disease 
and excessive inflammation. Over-activity of the different subsets, on the contrary, can contribute to diseases 
such as allergy and autoimmune disease, as indicated. 
pTreg
IFN-γ
IL-2
IL-4
IL-5    
IL-13
IL-17A
IL-17F
IL-22 
FOXP3
GATA3
Tbet
RORγt
TGF-β + IL-2
IL-2 + IL-4
IFN-γ + IL-12
IL-6 + IL-1β
(+ IL-21 / TGF-β)Naïve
CD4
Th1
Th2
Th17
Tfh
Bcl6
Main cytokines
produced
Health: 
Defending against
Disease:  
Contributing to
IL-21 + ICOS
(+ IL-6 / IL-12 / TGF-β) pathogens
neutralized
by antibodies
IL-21 
IL-4
autoimmune 
disease; 
allergy
intracellular
pathogens
(bacteria, virus)
extracellular
pathogens
(parasites)
extracellular
pathogens
(fungi, bacteria)
autoimmunity;
excessive
inflammation
autoimmune 
disease
autoimmune 
disease
allergy
cancer
STAT1/4
STAT5/6
STAT3
STAT3
STAT5
 6 
 
Dividing Thelper cells into subsets is certainly a useful model when thinking about their 
biological roles and functions, but it is worth bearing in mind that it is a simplification. 
There are more and more Thelper cell populations discovered. One explanation to this is that 
it has been shown that depending on the time, place and conditions there are Thelper cell 
types that co-express markers and even functionalities of multiple subsets and also one 
subset can be cross-differentiated into another subset (Caza and Landas, 2015; Geginat et 
al., 2014). The more the technologies for measuring and analyzing multiple markers at a 
time on single cell level progress, the more it has been becoming clear that the classical 
distinction into few subsets is only a simplified guideline (Wong et al., 2016). Instead, there 
is accumulating evidence against the traditional discrete classification of Thelper cell subsets, 
and the available information rather seems to support a conceptual model where the types 
of Thelper cells are continuous (as opposed to discrete) and they are not terminally fixed; this 
is also referred to as plasticity. 
 
1.3 Thelper cells in Multiple Sclerosis (MS) 
 
1.3.1 MS: an autoimmune disease 
 
One of the diseases where autoreactive T cells play an important role is Multiple Sclerosis 
(MS). MS is an autoimmune neuroinflammatory disease, in which immune cells infiltrate 
the central nervous system (CNS) and cause inflammation and tissue destruction [reviewed 
in (Becher et al., 2016; Dendrou et al., 2015; Goverman, 2009)]. Specifically, this 
destruction involves demyelination – that is, destruction of the myelin sheath which 
normally forms the electrically insulating surrounding layer around the axons of some 
nerve cells, such as in the white matter of the brain. Myelin consists of different cell types, 
lipids and proteins including myelin basic protein (MBP), myelin oligodendrocyte 
glycoprotein (MOG) and proteolipid protein (PLP) [reviewed in (Mallucci et al., 2015)]. 
The Thelper cells contributing to MS are believed to recognize peptides derived from myelin 
protein components as a self-antigen (i.e. they are autoreactive), and corresponding self-
antigens have been identified from MOG, PLP, MBP and other proteins. Also, certain 
viruses which share binding-motifs for MHC class II and TCR binding with MBP have 
been proposed as potential triggers of MS [reviewed in (Mallucci et al., 2015)]. The 
autoreactive T cells and other immune cells can pass the blood brain barrier in MS, that is 
facilitated by expression of the appropriate chemokine receptors, and in the CNS they 
secrete cytokines that signal to other immune cells such as macrophages, which then 
destroy the myelin sheath. Thus, one key feature of Thelper cells that are harmful in MS is the 
set of cytokines they produce, i.e. their cytokine profile. 
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1.3.2 Characterization and differentiation of pathogenic auto-reactive Thelper cells  
 
The molecular and cellular mechanism of MS and the role that specific cytokines play in it 
can be studied by interventional experiments in mice (and rats). Specifically, knockout or 
conditional knockout strains and/or cell transfer experiments have been used in 
combination with disease induction by peptides from protein components of myelin which 
leads to experimental autoimmune encephalomyelitis (EAE), the rodent model of MS. 
Furthermore, specific T cells from TCR-transgenic mice expressing TCRs that recognize 
myelin autoantigens such as MBP peptides have been useful tools (Kuchroo et al., 1994). In 
contrast, studies of human MS are limited to observational approaches, for example by 
studying the relationship between genetic variation [single-nucleotide polymorphism 
(SNP), copy number variation (CNV)] and disease risk or disease characteristics, which 
usually allows for identification of associations. 
 
A crucial element in understanding the role of T cells in MS would be to identify the 
cytokine(s) that confer pathogenic functions to T cells, both those cytokines acting on the 
differentiating T cells as well as the cytokines produced by the T cells themselves. 
 
From studies applying EAE models in mice and from descriptive human MS case-control 
studies, the T cell-released cytokines that have been identified to possibly have a role in the 
etiology of MS and EAE are IL-17A/F, IFN-γ, IL-22 and GM-CSF (Codarri et al., 2011; 
Hartmann et al., 2014; Noster et al., 2014; Ponomarev et al., 2006; Ramesh et al., 2014; 
Rolla et al., 2014). 
 
A multitude of studies has focused on Th17 cells as one important cell subset involved in 
EAE induction (Cua et al., 2003; Langrish et al., 2005; McGeachy et al., 2009), and hence 
in vitro differentiation conditions allowing polarization towards the Th17 subset have been 
applied. In detail, it has been shown that Thelper cells differentiated under Th17-polarizing 
conditions in the presence of IL-23 were capable of inducing EAE (i.e., are “pathogenic”), 
unlike those differentiated in the presence of IL-12 (Cua et al., 2003; Parham et al., 2002).  
Furthermore, IL-23 has been shown to be necessary for induction of IL-17A/F producing 
CD4+ T cells in vivo since IL-23 (p19) knockout mice lack IL-17A/F + cells (Langrish et 
al., 2005). These observations pointed to the importance of IL-23 as a central cytokine in 
EAE, and to murine IL-17 producing Thelper cells (Th17) as key Thelper subset in EAE (Cua 
et al., 2003; Langrish et al., 2005; McGeachy et al., 2009). However, mice deficient in IL-
17A or IL-17F were still susceptible to EAE (Haak et al., 2009), suggesting that other 
properties than IL-17 expression, but correlating with the EAE-inducing pathogenic “Th17” 
phenotype, may be involved in pathogenicity. 
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IL-23 is a cytokine not produced by T cells, and the above findings were especially 
interesting because the heterodimeric proteins IL-12 and IL-23 share the p40 subunit, and 
hence the later discovered IL-23 may be the explanatory factor for divergent outcomes in 
clinical studies targeting the different subunits of IL-12 in human immune diseases (Teng et 
al., 2015). 
 
In mice, IL-23, TGF-b3 and IL-1b have been shown to act as induction factors of 
pathogenic “Th17” cells, although such studies require in-depth analysis for accurate 
interpretation since the given cytokines have never demonstrated the effect alone, only in 
combination with other cytokines suggesting that their effects are conditional (El-Behi et 
al., 2011; Ghoreschi et al., 2010; Kara et al., 2015; Langrish et al., 2005; Lee et al., 2012; 
Wu et al., 2013). It has also been suggested that a modest increase in sodium chloride 
(NaCl) concentration in the cell culture medium towards physiological levels is able to 
induce pathogenic Th17 cells by activating the salt-sensing kinase SGK1, which in turn 
increases IL-23R expression, thereby enhancing the IL-23R signaling pathway 
(Kleinewietfeld et al., 2013; Wu et al., 2013). TGF-b3 has been proposed to be 
endogenously secreted as a result of IL-23R signaling, and subsequently conferring 
pathogenic properties on the developing Th17 cells (Lee et al., 2012). However, this is yet 
to be confirmed, since another independent study has shown that Th17 cells induced in the 
presence of either TGF-b1 or TGF-b3 were not pathogenic (Lee et al., 2015).  
 
Given the above experimental results and considering that both non-pathogenic and 
pathogenic (EAE-inducing) Th17 cells express IL-17 in this animal model, the question 
arises: what makes a “Th17” cell pathogenic? In other words, even though each of the Th17 
cell populations induced under different Th17-polarizing conditions produced IL-17, not all 
of them were able to induce EAE in cell transfer experiments. Furthermore, complete or 
T cell-specific deficiency of IL-17 did not prevent EAE induction (Codarri et al., 2011; 
Haak et al., 2009). Together, these observations suggest that IL-17 itself is not sufficient for 
disease induction. 
 
To understand the difference between the pathogenic and non-pathogenic “Th17” 
populations, the transcriptome of Th17-polarized cells induced by different corresponding 
cytokine cocktails has been studied, showing that pathogenic and non-pathogenic 
populations expressed different sets of genes. Consequently, signature genes associated 
with pathogenic or non-pathogenic Th17 cells have been suggested (Gaublomme et al., 
2015; Ghoreschi et al., 2010; Lee et al., 2012; Wu et al., 2013).  
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One of the genes associated with a pathogenic signature is the gene Csf2 (Colony 
Stimulating Factor 2) encoding for the cytokine granulocyte-macrophage colony 
stimulating factor (GM-CSF). When added during in vitro differentiation of murine Th17 
cells, IL-1b and IL-23 induced GM-CSF+IL-17+ double-positive cells (El-Behi et al., 2011). 
Similarly, Th17 cells differentiated in the presence of TGF-b3 or elevated NaCl 
concentrations displayed increased Csf2 expression on the population level, but have not 
been studied at single cell resolution (Lee et al., 2012; Wu et al., 2013). A more recent 
study has used single cell RNA-sequencing to analyze the heterogeneity of murine Th17 
cells isolated ex vivo from the lymph nodes or CNS of mice at the peak of EAE disease, or 
differentiated in vitro under pathogenic (IL-23 + IL-1b + IL-6) or non-pathogenic (TGF-
b1 + IL-6) Th17 conditions (Gaublomme et al., 2015). Here, sorted IL-17+ cells displaying 
a Th1-like memory cell phenotype from the CNS up-regulated Csf2 mRNA (Gaublomme et 
al., 2015). Interestingly and against the notion of IL-23, SGK1 and GM-CSF being crucial 
in pathogenic Th17 differentiation, IL23R- or SGK1-deficient T cells differentiated under 
Th17-polarizing conditions expressed increased Csf2 levels compared to the wild-type 
counterpart (Wu et al., 2013). 
 
Altogether, these studies shed light on the different cell populations involved in EAE, but 
due to the overlapping patterns of the different signature cytokines from the diverse Th cell 
subsets it is difficult to conclude which cytokines are actually necessary for pathogenicity 
and which ones are just associated with the pathogenic phenotype, either on single cell level 
or even only on the population level due to similar inducing factors. To study which 
cytokines are necessary in EAE induction, key experiments were those with cytokine-
knockout models, which showed that deficiency of either IL-17A, IFN-γ, or GM-CSF 
specifically in T cells impaired their pathogenic potential, at least to some extent (Codarri et 
al., 2011). 
 
1.3.3 GM-CSF as a crucial cytokine in MS 
 
As described above, there are several cytokines that have been implicated in MS based on 
studies using knockout and other approaches, but the one that really seems to stand out is 
GM-CSF encoded by the gene CSF2. GM-CSF has been shown to be necessary for EAE 
induction in mice, since mice lacking the gene encoding GM-CSF (Csf2) do not develop 
EAE upon induction, unlike their wild-type counterpart (McQualter et al., 2001). In fact, 
GM-CSF deficiency led to complete resistance to EAE induction. In contrast, lack of IL-
17A, IL-17F or IFN-γ had no or only marginal effects on susceptibility to EAE disease 
induction (Ferber et al., 1996; Haak et al., 2009). 
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It is worth noting though that these experiments might be confounded by the fact that GM-
CSF is also an important factor for the development of the myeloid lineage, therefore these 
mice might have an abnormal immune system, and it might be more advantageous to use 
conditional knockout strains such as those lacking GM-CSF specifically in T cells. Similar 
issues of potential systemic effects apply to knockout mice for other cytokines. An 
alternative to the use of conditional knockout strains is to perform adoptive transfer 
experiments with T cells that are deficient in the cytokine of interest into cytokine-
sufficient mice, and in this context, TCR transgenic T cells recognizing myelin-derived 
auto-antigens are particularly useful for studying EAE. Confirming the role of T cell-
derived GM-CSF, it has been demonstrated in mice by cell transfer experiments with 
cytokine knockout T cells that GM-CSF produced in particular by autoreactive T cells is 
necessary for the onset of EAE (Codarri et al., 2011; Ponomarev et al., 2006). Furthermore, 
it was demonstrated that GM-CSF production by “Th1” and “Th17” cells is required for 
their encephalitogenicity (El-Behi et al., 2011). Importantly, INF-γ as well as IL-17A 
production by T cells was dispensable, while GM-CSF production was necessary for 
induction of EAE (Codarri et al., 2011; Ponomarev et al., 2006). Along the same lines, 
murine T cells polarized to produce GM-CSF induced more severe EAE upon adoptive 
transfer compared those polarized to produce IFN-γ or IL-17, although the latter also 
induced disease (Codarri et al., 2011). However, overlapping cytokine profiles of such in 
vitro polarized cells cannot be excluded.  
 
Despite the important insights that have been derived from above-described animal studies 
with the EAE and other models, it remains debated to which extent these results reflect the 
situation in human MS, since obviously experiments to test the pathogenicity of certain cell 
populations are not possible in human. 
 
Regarding the human biology, from observational experiments GM-CSF seems to be 
associated with MS since it has been shown that at the site of disease, in the cerebrospinal 
fluid, there are increased frequencies of GM-CSF producing Thelper cells in MS patients 
compared to controls (Noster et al., 2014). The fraction of GM-CSF producing CD4+ T 
cells was not elevated in peripheral blood of MS patients in the same study (Noster et al., 
2014), although this was observed in another report (Hartmann et al., 2014). IFN-γ 
production in CD4+ T cells showed the same pattern as GM-CSF, with increased fractions 
of IFN-γ+ cells in cerebrospinal fluid of MS patients compared to controls, while the 
fraction of IL-17+ cells did not significantly differ between the two groups in the same 
study (Noster et al., 2014). Notably, myelin-reactive T cells have been detected in both MS 
patients as well as healthy donors with comparable frequencies, but have been determined 
to produce more IFN-γ, IL-17 and GM-CSF and at the same time less IL-10 in MS patients 
compared to healthy donors, in both oligoclonal populations or single cell-derived clones of 
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myelin-reactive T cells (Cao et al., 2015). While Th17 cells producing GM-CSF have been 
proposed as pathogenic cells in EAE, in the human MS studies, GM-CSF rather seems to 
associate with Th1-like than with Th17-like cells. Although differences in murine and 
human CD4+ subset differentiation and classification emerge, rodent models have been 
used to enhance the understanding of which T cells are involved in the pathogenesis of 
EAE, which may or may not reflect the scenario in MS depending on the specific 
conditions and cells under study.  
 
Interestingly, enhanced GM-CSF levels including elevated frequencies of GM-CSF 
producing CD4+ T cells have also been observed in another human autoimmune disease at 
the site of inflammation – that is, synovial fluid of patients with juvenile arthritis (Piper et 
al., 2014; Wicks and Roberts, 2015). According to an assumed important role of GM-CSF 
in these diseases, several ongoing clinical studies are based on neutralizing GM-CSF in MS 
or arthritis (Wicks and Roberts, 2015). 
 
1.3.4 Induction and phenotype of GM-CSF producing CD4+ T cells 
 
As described above, GM-CSF produced by autoreactive T cells seems to play an important 
role in the pathogenesis of MS. But how does GM-CSF fit into our view of classical Thelper 
cell subsets? There are several Thelper cell subsets, each one with a specific cytokine profile 
and function, and each one differentiates when a certain cytokine environment is present 
(see paragraph 1.2, Figure 2), but it remains unclear how to position GM-CSF producing 
CD4+ T cells in the Thelper subset space. 
 
GM-CSF production has been detected in cells that may be classified to other Th subsets 
(such as those co-expressing IFN-γ, IL-3, or IL-17). As described above, IL-17 and GM-
CSF can be co-expressed in murine T cells (El-Behi et al., 2011) but interestingly, their 
expression was mutually exclusive in human CD4+ T cells at least in one study (Noster et 
al., 2014). Here, GM-CSF can be co-expressed with other lineage-defining cytokines such 
as IFN-γ, but interestingly GM-CSF single-positive (“GM-CSF only”) human CD4+ T cells 
that do not express other classifying cytokines or lineage-defining transcription factors have 
also been observed (Noster et al., 2014; Zielinski, 2014). However, whether the GM-CSF 
producing T cells are a specific subset of T cells, and if so which markers define it, is 
unclear to date.  
 
In vitro differentiation of T cells has been used as an experimental system aiming to gain 
knowledge about factors regulating GM-CSF production in human CD4+ T cells, with 
partially conflicting results and several open questions (summarized in Figure 3). For 
example, TGF-b1 or TGF-b3 were found to decrease GM-CSF production in human CD4+ 
 
 11 
myelin-reactive T cells (Cao et al., 2015). While Th17 cells producing GM-CSF have been 
proposed as pathogenic cells in EAE, in the human MS studies, GM-CSF rather seems to 
associate with Th1-like than with Th17-like cells. Although differences in murine and 
human CD4+ subset differentiation and classification emerge, rodent models have been 
used to enhance the understanding of which T cells are involved in the pathogenesis of 
EAE, which may or may not reflect the scenario in MS depending on the specific 
conditions and cells under study.  
 
Interestingly, enhanced GM-CSF levels including elevated frequencies of GM-CSF 
producing CD4+ T cells have also been observed in another human autoimmune disease at 
the site of inflammation – that is, synovial fluid of patients with juvenile arthritis (Piper et 
al., 2014; Wicks and Roberts, 2015). According to an assumed important role of GM-CSF 
in these diseases, several ongoing clinical studies are based on neutralizing GM-CSF in MS 
or arthritis (Wicks and Roberts, 2015). 
 
1.3.4 Induction and phenotype of GM-CSF producing CD4+ T cells 
 
As described above, GM-CSF produced by autoreactive T cells seems to play an important 
role in the pathogenesis of MS. But how does GM-CSF fit into our view of classical Thelper 
cell subsets? There are several Thelper cell subsets, each one with a specific cytokine profile 
and function, and each one differentiates when a certain cytokine environment is present 
(see paragraph 1.2, Figure 2), but it remains unclear how to position GM-CSF producing 
CD4+ T cells in the Thelper subset space. 
 
GM-CSF production has been detected in cells that may be classified to other Th subsets 
(such as those co-expressing IFN-γ, IL-3, or IL-17). As described above, IL-17 and GM-
CSF can be co-expressed in murine T cells (El-Behi et al., 2011) but interestingly, their 
expression was mutually exclusive in human CD4+ T cells at least in one study (Noster et 
al., 2014). Here, GM-CSF can be co-expressed with other lineage-defining cytokines such 
as IFN-γ, but interestingly GM-CSF single-positive (“GM-CSF only”) human CD4+ T cells 
that do not express other classifying cytokines or lineage-defining transcription factors have 
also been observed (Noster et al., 2014; Zielinski, 2014). However, whether the GM-CSF 
producing T cells are a specific subset of T cells, and if so which markers define it, is 
unclear to date.  
 
In vitro differentiation of T cells has been used as an experimental system aiming to gain 
knowledge about factors regulating GM-CSF production in human CD4+ T cells, with 
partially conflicting results and several open questions (summarized in Figure 3). For 
example, TGF-b1 or TGF-b3 were found to decrease GM-CSF production in human CD4+ 
 12 
T cells in one study (Hartmann et al., 2014), while TGF-b1 had no effect in another (Noster 
et al., 2014). IL-23 and IL-6 did not augment GM-CSF (Hartmann et al., 2014; Noster et 
al., 2014), whereas IL-2 or IL-7 signaling induced GM-CSF expression in a STAT5-
dependent manner, and IL-1b induced IFN-γ+ GM-CSF+ double-positive cells (Hartmann et 
al., 2014; Noster et al., 2014). 
 
 
 
 
 
 
 
 
 
Figure 3: Factors known to influence the differentiation of GM-CSF producing Thelper cells, and the 
transcription factors, cytokines and functions linked to them. The cytokines given in grey have been 
described to enhance differentiation, while factors in orange have been described to inhibit the differentiation 
of GM-CSF producing Thelper cells. Cytokines in parentheses showed the indicated effect in only some but not 
all studies, and/or differ between mouse and human. In blue, the STAT family member (STAT5) reported be 
involved is shown. Question mark indicates that no “master transcription factor” has been identified for GM-
CSF producing Thelper cells. The cytokines described to be co-produced with GM-CSF are shown in black. 
Thelper cell produced GM-CSF has been reported to play a role in protection against diverse infections and in 
the pathology of autoimmune disease, such as multiple sclerosis (MS) and rheumatoid arthritis (RA). 
 
 
 
 
 
 
Altogether, the above studies imply that GM-CSF produced by CD4+ T cells is a crucial 
contributor to MS and EAE. So far it has not been clearly defined whether GM-CSF 
producing T cells are a separate subset and if so, what their lineage-defining transcription 
factor is or which other markers may enable the identification of these cells. Understanding 
the generation and characteristics of GM-CSF+ CD4+ T cells may be important to improve 
treatment options for patients with autoimmune diseases in the future. 
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2 AIMS 
 
The overall aim of this thesis was to characterize the differentiation and molecular 
properties of human Thelper cell subsets that contribute to multiple sclerosis (and other 
autoimmune diseases) by combining experimental and computational approaches. Here, the 
focus was especially on those Thelper cells producing the cytokines GM-CSF, IFN-γ, and/or 
IL-17. 
 
The specific aims per paper were the following: 
 
Paper I 
¾ Identify promoting and inhibitory cytokines and other environmental signals for the in 
vitro differentiation of human GM-CSF producing Thelper cells from naïve CD4+  
T cells 
¾ Quantify the similarity of human GM-CSF producing Thelper cells to other Thelper cell 
subsets, both on single cell and population level using computational flow cytometry 
¾ Define subpopulations of human GM-CSF producing Thelper cells and map them to the 
inducing cytokine signals 
Paper II 
¾ Explore the regulation & function of FOXP3 isoforms in the differentiation of pro-
inflammatory Thelper subsets 
Paper III 
¾ Develop a user-friendly web-based platform that allows the application of a wide 
range of machine learning and causal discovery methods on flow and mass cytometry 
data (some of these methods have been applied in Paper I programmatically) 
Paper IV 
¾ Identify the defining characteristics of human GM-CSF producing Thelper cells as well 
as memory Thelper cells ex vivo in terms of both gene expression and chromatin 
accessibility 
¾ Reconstruct a directed gene regulatory network representing the transcription factor 
binding events that define the molecular profile of human GM-CSF producing Thelper 
and memory Thelper cells 
¾ Assign pathways and diseases that are associated with the profile of human GM-CSF 
producing Thelper cells and memory Thelper cells 
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3 RESULTS 
 
3.1 Computational flow cytometry studies on the differentiation of pro-inflammatory 
Thelper subsets 
 
Both GM-CSF and IL-17 producing Thelper cells are pro-inflammatory T cell subsets, and 
they both have been implicated in autoimmune diseases, such as MS and RA. In Paper I 
and Paper II, I studied the differentiation of these Thelper cell subsets from different aspects 
(discussed below). Paper I involved analysis of large amounts of flow cytometry data and it 
is also concerned with application of advanced statistical methods on cytometry data, while 
Paper III is concerned with the development of a user-friendly platform for such tasks. 
 
3.1.1 Factors affecting GM-CSF producing Thelper cell differentiation – Paper I 
 
3.1.1.1 Cytokine effects 
 
GM-CSF producing Thelper cells have been associated with MS and EAE, but it has not been 
clearly determined which cytokines induce or repress their differentiation. There are few 
studies on this question in the literature, and even among that few, some of the conclusions 
are contradictory, which may be explained by differences in terms of species or 
experimental system. For example, IL-23 has been shown to promote the differentiation of 
GM-CSF producing Thelper cells in mice (El-Behi et al., 2011) but repress it in human in 
vitro experiments (Noster et al., 2014). 
 
Therefore, in this part of the thesis the following question was addressed: What cytokines 
promote or repress the differentiation of human GM-CSF producing Thelper cells? The 
approach here was to use in vitro T cell differentiation assays and data-driven analysis of 
cytokine effects. For this purpose, freshly isolated naïve CD4+ T cells were cultured in the 
presence of anti-CD3/CD28 coated activating beads and various cytokines (that were 
previously described to influence the differentiation of Thelper subsets) or combinations 
thereof as “cytokine cocktails”. After 5 days (unless otherwise indicated), GM-CSF as well 
as other markers (for Thelper subsets and activation) were quantified by flow cytometry. 
Importantly, in this study all the cytokine effects were measured under the same 
experimental conditions, therefore they were directly comparable. 
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In order to quantify the GM-CSF promoting or inhibitory effects in human Thelper cells that 
can be attributed to specific cytokines and cytokine pairs, least absolute shrinkage and 
selection operator (LASSO) linear regression was applied. This type of regression is 
advantageous to prevent overfitting since it includes regularization and it is also useful for 
selection of the simplest and most accurate model by performing cross-validation. After 
cross-validation one can inspect the mean cross-validated error as a function of the 
regularization parameter (l or ln(l)) and choose the regularization parameter value (thereby 
the model) with the smallest mean cross-validated error. 
 
This analysis showed that TGF-b strongly induced the differentiation of GM-CSF 
producing Thelper cells, especially when combined with IL-1b. On the other hand, IL-23 had 
a repressing effect. This was conceptually unexpected since GM-CSF has been described to 
contribute to inflammatory diseases and classically TGF-b is referred to as an anti-
inflammatory cytokine, although context dependent effects have been described [reviewed 
in (Massagué, 2012; Morikawa et al., 2016)], and IL-23 is referred to as a pro-inflammatory 
cytokine. The inhibitory effect of IL-23 on GM-CSF expression observed herein was in line 
with a study on human Thelper cells (Noster et al., 2014) but not with a different study in 
mice (El-Behi et al., 2011). 
 
3.1.1.2 Context dependency 
 
In human, TGF-b was shown to inhibit GM-CSF expression in Thelper cells in one study 
(Noster et al., 2014), it had no significant effect in another study (Hartmann et al., 2014), 
and in the present study it induced the expression of GM-CSF in human Thelper cells. 
Therefore, to find an explanation for this discordance, differences in terms of experimental 
conditions (protocol) were investigated and compared. An important difference between 
this and the other studies was the type of activation. In addition, sodium concentration has 
been previously described to influence the differentiation of Thelper cells (Kleinewietfeld et 
al., 2013; Wu et al., 2013). Therefore, the effect of these factors was further investigated. 
 
In our experiments, bead-bound anti-CD3/CD28 activation was used, whereas in the studies 
of (Hartmann et al., 2014; Noster et al., 2014) plate-bound anti-CD3 and soluble anti-CD28 
based activation was used. Therefore, these two types of in vitro activation were compared 
in the present work with regards to their effect on GM-CSF expression in activated human 
Thelper cells, in the presence or absence of TGF-b. In these experiments, with anti-CD3 and 
soluble anti-CD28 based activation TGF-b showed an inhibitory effect on GM-CSF 
expression, which matched the observation described by (Noster et al., 2014). Therefore, 
activation type might be one factor that can explain the different effects of TGF-b observed 
on GM-CSF expression. 
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The other factor further tested was the sodium chloride (NaCl) concentration in the 
medium, which has been described to modulate Thelper cell differentiation (see section 1.3.2, 
(Kleinewietfeld et al., 2013; Wu et al., 2013)). Interestingly, my results showed that TGF-b 
had a promoting effect on the differentiation of GM-CSF producing Thelper cells in the 
presence of physiological sodium chloride concentration, and a repressing effect in the 
presence of low sodium chloride concentration. 
 
Since TGF-b affected GM-CSF expression in human Thelper cells differently, depending on 
what type of activation and what concentration of sodium chloride was present, a 
possibility to consider was that the activation type and/or sodium chloride concentration 
modulates the total percentage of GM-CSF producing Thelper cells only by influencing the 
extent of proliferation, thus indirectly. To control for this and to determine whether this was 
the case, throughout the experiments investigating the effect of activation type and sodium 
chloride concentration, cells were labelled with a proliferation dye and the percentage of 
GM-CSF producing Thelper cells was analyzed conditioning on the cumulative number of 
cell cycles. This showed that the differential effect of TGF-b, depending on activation type 
or sodium chloride concentration, was independent of proliferation. In addition, the effect 
of TGF-b on GM-CSF expression was investigated in the presence or absence of a STAT5 
inhibitor. Conditioning on the cumulative number of cell cycles, the results showed that the 
GM-CSF promoting effect of TGF-b (with bead-bound anti-CD3/CD28 activation, and 
physiological sodium chloride concentration) was independent of the STAT5 signaling 
pathway. 
 
These results exemplify the possible context dependent effects of cytokines, and emphasize 
the importance of experimental design. 
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3.1.2 Positioning GM-CSF producing Thelper cells in the Thelper space – Paper I 
 
It has not been clearly determined according to the available literature whether GM-CSF 
producing Thelper cells are a distinct Thelper cell population and to which other subsets they 
are most similar to (see section 1.3.4). Therefore, these questions are addressed in the 
following sections. 
 
3.1.2.1 GM-CSF as an individual cytokine 
 
First, the pairwise Spearman correlation was investigated between GM-CSF as a cytokine 
and several other main Thelper subset markers in two different ways: (i) on the population 
level across stimulation conditions (here stimulation conditions be thought of as 
“perturbations”), and on the single cell level, i.e. across single cells, treating the stimulation 
conditions as replicates. Interestingly, the results differed in the two different cases: FOXP3 
was highly correlated with GM-CSF on the population level across conditions, and IFN-g 
was highly correlated with GM-CSF on single cell level under the different conditions. This 
suggested the possibility that GM-CSF and FOXP3 might be induced by similar cytokine 
signals in human differentiating Thelper cells but on the intracellular pathway level they 
might be rather independently regulated. On the other hand, IFN-g might be co-regulated 
with GM-CSF on the intracellular pathway level, since under various stimulation conditions 
their expression co-varies across single cells. 
 
3.1.2.2 GM-CSF producing Thelper cells as a cell population  
 
As part of assessing the similarity of GM-CSF producing Thelper cells to other Thelper subsets, 
next, the composition of the GM-CSF producing Thelper cell population was investigated. 
Here, the aim was to determine: (i) whether they are a homogenous population, (ii) whether 
different stimuli give rise to different subsets within GM-CSF producing Thelper cells, and 
(iii) to what extent these subsets express the other main Thelper subset markers included in 
the analysis. 
 
It is worth noting that the semantics of what we mean by a subset (or “cell population”) is 
not obvious, and it is useful to explicitly clarify this. Although defining a cell population as 
“cells with identical function” might be most appropriate in a biological sense, here we 
define cell populations purely in a data-driven way as “clusters” of cells based on their 
multivariate distribution. 
 
To address the above questions, t-SNE dimensionality reduction and model based 
clustering was used to identify and analyze subgroups of GM-CSF producing Thelper cells. 
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This analysis showed, that GM-CSF producing Thelper cells are heterogeneous with respect 
to other Thelper subset markers and that the population composition depends on the cytokine 
environment since it differed in the presence or absence of TGF-b. For example, in the 
presence of TGF-b there was a subpopulation present resembling to Tregs, showing high 
FOXP3 and CD25 expression, and low expression of IL-2. However, these are necessary 
but not sufficient hallmarks of Tregs, and in human, FOXP3 can also be induced simply by 
T cell activation (Pillai et al., 2007; Wang et al., 2007). 
 
These results together showed that GM-CSF producing Thelper cells can be induced in 
multiple different ways and that the composition of the cell population is dependent on the 
mode of induction. Therefore, conceptually relating the process of Thelper cell differentiation 
from single cell to population level seems complex, and in the future, definition and 
experimental testing of theoretical frameworks might help to better understand this 
relationship (Hong et al., 2012). 
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3.1.3 Regulation & function of FOXP3 isoforms in Thelper cells – Paper II 
 
FOXP3, known as the master regulator transcription factor of Tregs, exists in several 
alternative splice isoforms (in human but not in mouse) and the role of this diversity is not 
completely understood (Aarts-Riemens et al., 2008). It has been shown that the FOXP3 
isoform lacking exon 2 and exon 7 is not fully functional (Mailer et al., 2009). Initial 
experiments from this study suggested that Crohn’s disease patients expressed higher levels 
of the FOXP3 isoform that lacks exon 7, compared to healthy donors, without the total 
FOXP3 expression being significantly different between the groups. Therefore, we wanted 
to study further the reasons and consequences of FOXP3 isoform differences. 
 
In order to identify cytokines that modulate alternative splicing of FOXP3, we chose to 
activate Tregs in the presence of IL-1b, IL-6 or TNF-a, since FOXP3 naturally occurs in 
Tregs and these cytokines are key pro-inflammatory cytokines, thus possibly having a role 
in shifting the balance of immune regulation. Of these cytokines, IL-1b was able to increase 
the expression the FOXP3 isoform lacking exon 7 in activated Tregs. 
 
An interesting connection might be that in Paper I IL-1b alone but especially IL-1b 
together with TGF-b (that is known for its FOXP3 inducing effect), also promoted the 
differentiation of GM-CSF producing Thelper cells. It might be interesting to see in the future 
whether these induced GM-CSF producing Thelper cells have any alteration in the balance of 
FOXP3 isoforms. 
 
IL-17 has been linked to several autoimmune diseases, as well as GM-CSF (that is studied 
in Paper I and Paper IV). IL-2 is a cytokine generally important for T cell activation. In 
order to identify cytokines that are modulated by FOXP3 alternative splicing, we induced 
alternative splicing of FOXP3 by transfecting Tregs with morpholino antisense 
oligonucleotides (MAO) that prevent binding of splice-directing small nuclear 
ribonucleoproteins to the exon-exon boundaries of FOXP3 pre-mRNA [reviewed in (Kole 
et al., 2012)], and measured the percentage of IL-2 and IL-17 producing cells by flow 
cytometry. These experiments showed that removal of exon 7 in Tregs increased the 
percentage of IL-2 producing cells, and removal of both exon 2 and exon 7 increased the 
percentage of both IL-2 and IL-17 producing cells. 
 
In order to test whether there is an association between altered FOXP3 isoform levels and 
IL-17 levels in a disease setting, we quantified the relative expression of FOXP3 isoforms 
and IL-17, and analyzed the correlation between them using colon biopsies from Crohn’s 
disease patients. Quantified by rank based Spearman correlation, IL-17 was significantly 
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correlated with the FOXP3 isoform lacking exon 7 in affected tissue from Crohn’s disease 
patients. 
 
This study can serve as an example showing how the regulation and balance of pro- and 
anti-inflammatory processes are interconnected. 
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3.1.4 A web based tool for computational analysis of single cell cytometry data – 
Paper III 
 
Throughout all the studies in this thesis, and especially heavily in Paper I, flow cytometry 
was used to measure responses and behavior of T cells on the single cell level. Flow 
cytometry and its newer relative mass cytometry can be extremely valuable tools due to 
their ability to measure (i) multiple variables, (ii) on the single cell level, (iii) in a large 
number of cells. But in practice, they are only as valuable as the extent to which we are able 
to extract and interpret information from the data they produce. Exactly due to their high 
dimensional nature and their large sample sizes (number of cells), often combined with 
complex experimental design (for example time course with multiple groups and 
interventions, etc.), flow- and mass-cytometry data can be hard to interpret by eye. To draw 
conclusions from such data, various machine learning approaches can be useful (regression, 
dimensionality reduction, clustering to name a few). An example of how these methods can 
be used for flow- and mass-cytometry data is Paper I, but that is by no means a 
comprehensive example and there are far more possibilities of analysis depending on the 
question and the design of the experiments. 
 
Since application of machine learning or generally advanced statistical methods usually 
requires programming skills, let alone the theoretical background, these methods are 
usually not accessible to wet-lab biologists. Therefore, in Paper III we created a tool, that 
gives the possibility of applying such methods, to wet-lab biologists via a user-friendly 
interface, without the need for programming skills. Thus, in collaboration with computer 
science and data science experts, we created SCENERY (Single CEll NEtwork 
Reconstruction sYstem). 
 
SCENERY is web application that allows the users to upload cytometry data in FCS or text 
file (comma or tab separated) format, and to analyze this data. The different types of 
analysis are divided to three categories: pre-processing, statistical analysis, and network 
reconstruction. The structure of SCENERY is modular, therefore users can extend the set of 
the available analysis methods with new ones, given that the input/output of the new 
method complies with the standards of the web server. 
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3.2 Molecular profile & gene regulatory network of ex vivo memory & GM-CSF 
producing Thelper cells – Paper IV 
 
The aim in this part of the thesis work was to get a highly detailed picture and 
understanding of what makes a GM-CSF producing Thelper cell by studying their chromatin 
and transcriptome together, since this might be important due to their relevance in MS (see 
section 1.3.2 – 1.3.3). It was apparent from previous parts of the thesis that (i) GM-CSF 
producing Thelper cells can be induced in different ways, (ii) they are heterogeneous, and (iii) 
their expression properties depend on the induction conditions. Therefore, to characterize 
the gene regulation and expression profile of GM-CSF producing Thelper cells, I chose to use 
a more physiological system using ex vivo isolated GM-CSF producing Thelper cells. 
Physiological relevance was particularly important in this case since this study involved 
measurement and in-depth analysis of thousands of variables (genes and chromatin 
regions). 
 
The main contrast of interest was to compare GM-CSF producing vs. non-producing Thelper 
cells to each other. GM-CSF producing Thelper cells were isolated from total (bulk) CD4+ T 
cells by using a cytokine capture assay that contains an antibody construct that is 
immobilized to the cell surface and binds the secreted cytokine, and because the construct 
also contains metal beads, the cells can subsequently be isolated by magnetic bead 
isolation. This procedure yielded three cell populations: bulk, GM-CSF producing, and 
non-producing CD4+ T cells. The bulk population can serve as a control to estimate the 
effects on chromatin and transcriptome purely arising due to the GM-CSF capture assay 
procedure (that involves the use of a magnetic column), since the bulk population mostly 
consisted of GM-CSF non-producer cells and therefore it is ought to be very similar to the 
GM-CSF non-producer (negative) fraction, except that the latter one has been through the 
capture assay procedure. 
 
In addition, memory and naïve Thelper cells were used as controls for the following reasons: 
Memory Thelper cells are more likely to produce GM-CSF (and cytokines in general) than 
naïve Thelper cells. This means that when comparing the chromatin and transcriptome of 
GM-CSF producing vs. non-producing Thelper cells to each other, some of the differences 
inherently originate from the memory vs. naïve status. Therefore, to be able to account for 
the differences due to memory vs. naïve status, and separate these from the differences that 
arise due to GM-CSF producing vs. non-producing status, two additional cell populations 
were isolated and analyzed: memory and naïve Thelper cells. Also, apart from serving as 
controls, the comparison of memory vs. naïve Thelper cells is also interesting by itself, due to 
the fact that we they have not been studied before using chromatin and transcriptome data 
together. 
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The read-outs used in this study were ATAC-seq and RNA-seq to study the chromatin 
activity and gene expression respectively. The main comparisons to make were GM-CSF 
producing vs. non-producing (GM-CSF contrast) and memory vs. naïve Thelper cells 
(memory contrast). The aim was to integrate the two data types (ATAC-seq and RNA-seq) 
and to propose an explanation of the gene expression changes observed by RNA-seq, by 
identifying putative transcription factor binding events in active chromatin regions using 
the ATAC-seq data, and thus creating two gene regulatory networks corresponding to the 
memory and GM-CSF contrasts. 
 
3.2.1 Transcriptome analysis: differential expression & disease enrichment 
 
In order to identify differentially expressed genes (as well as differentially accessible 
chromatin regions), generalized linear models were used (based on the negative binomial 
distribution, edgeR (McCarthy et al., 2012; Robinson et al., 2010)). In these models, the 
independent variables were coded as dichotomous variables using the levels of cell types 
(GM-CSF-, GM-CSF+, bulk, naïve and memory CD4+ T cells) and the levels of the 
biological replicates, independently. The contrasts of interests extracted were the GM-CSF 
and the memory contrasts (defined above), and as a result of the model definition, the 
effects were adjusted for biological variability. 
 
Overall, based on the differential expression results and also based on dimensionality 
reduction (PCA & t-SNE), the memory contrast showed larger differences than the GM-
CSF contrast in terms of gene expression (of note, this was less pronounced on the level of 
chromatin accessibility measured by ATAC-seq). Among the differentially expressed 
genes, there were several with a described function in T cells. At the same time, an 
interesting set (~9%) of those genes differentially expressed in the GM-CSF contrast was 
unique this contrast (and was not differentially expressed in the memory contrast), and this 
contained several genes with unexplored function in T cells. 
 
When performing a rank based gene set enrichment using the combined measure of the 
significance and direction of differential expression in the GM-CSF contrast (-log10(FDR) 
´ sign(log2(Fold Change))) and gene sets corresponding to diseases, the significantly 
enriched diseases contained mostly immune diseases. Some of these, such as MS and RA, 
have been previously linked to GM-CSF producing Thelper cells. Mycobacterial infections 
were also significantly enriched diseases and the role of GM-CSF and GM-CSF producing 
Thelper cells has been described in these diseases (Chroneos et al., 2009; Denis and 
Ghadirian, 1990; Rothchild et al., 2017). Furthermore, several of the genes differentially 
expressed in this study in the GM-CSF contrast also showed altered expression between 
myelin reactive vs. non-reactive Thelper cell clones in MS patients but not in healthy controls 
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in the data from another study (Cao et al., 2015). The enrichment of several expected 
diseases was indicating that the data points to the right direction and that it is worth further 
exploration in a data driven way, possibly leading to unexpected conclusions as well. 
 
3.2.2 Prediction of transcription factor binding 
 
The chromatin activity was studied by a method called ATAC-seq. In brief, it is a method 
that is based on the idea that active chromatin regions are accessible, and these regions can 
therefore be cut by a transposase enzyme called Tn5 (Buenrostro et al., 2013). Thus, this 
method allows identification of accessible chromatin regions and therefore the study of 
chromatin activity and its relation to gene regulation. 
 
In this study, the main purpose of using ATAC-seq was to identify putative transcription 
factor binding events in active chromatin regions for gene regulatory network 
reconstruction. In order to identify putative transcription factor binding events three main 
steps are necessary: peak-calling to identify accessible chromatin regions, footprinting in 
accessible regions to identify sites where binding of a transcription factor is likely, and 
motif scanning in the footprints to make a statistically educated guess regarding which 
transcription factor is a likely binder in the footprint. By applying this procedure, a genomic 
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The directed network reconstruction was carried out both for the GM-CSF contrast (“GM-
CSF network”) and also for the memory contrast (“Memory network”) and the networks 
were analyzed in side-by-side fashion. The reconstruction procedure consisted of two main 
steps: identification of source nodes, and identification of target nodes. 
 
3.2.3.1 Identifying source nodes 
 
This step was based on the idea that important transcription factors (source nodes) are 
likely to bind a high fraction of differentially accessible peaks, in other words they have a 
global effect. Therefore, peaks were ranked based on their combined measure of 
significance and direction of differential accessibility (-log10(FDR) ´ sign(log2(Fold 
Change))), resulting in a ranked list of peaks. The peaks that contained footprints were 
scanned for transcription factor binding motifs, resulting in transcription factor binding 
sites along the ranked peak list. In order to identify transcription factors with binding sites 
significantly enriched in differentially accessible peaks, a normalized enrichment score was 
calculated (as in gene set enrichment analysis (GSEA), (Subramanian et al., 2005)), and 
random sampling was performed on the ranked peak list to generate a null distribution and 
examine how probable it would be to obtain at least the observed enrichment by chance (p 
value) (Sergushichev, 2016). After multiple test correction, transcription factors were 
selected based on their FDR values (FDR < 0.05 cutoff) and they were ranked based on 
their normalized enrichment score. With this approach, approximately two dozen key 
transcription factors were identified for both the GM-CSF and memory contrasts. 
 
3.2.3.2 Identifying target nodes 
 
The next step in the directed network reconstruction was to select target nodes. Target 
nodes in this case are peaks, with a gene assigned to them. The selection criteria were that 
the peak has to (i) contain a footprint with a binding motif of the source node (transcription 
factor) and the peak has to be (ii) either differentially accessible and/or the gene assigned to 
it has to be differentially expressed. 
 
3.2.3.3 Node & network analysis 
 
Before investigating the functional impact of transcription factors (source nodes) based on 
the network structure, there are a few properties of the transcription factors (based on the 
data) that are worth considering, since they might be necessary for the transcription factors 
to play an important role. These are the relative abundance and differential expression of 
transcription factors. The notion is that the transcription factor might have to be present at 
 
26 
The directed network reconstruction was carried out both for the GM-CSF contrast (“GM-
CSF network”) and also for the memory contrast (“Memory network”) and the networks 
were analyzed in side-by-side fashion. The reconstruction procedure consisted of two main 
steps: identification of source nodes, and identification of target nodes. 
 
3.2.3.1 Identifying source nodes 
 
This step was based on the idea that important transcription factors (source nodes) are 
likely to bind a high fraction of differentially accessible peaks, in other words they have a 
global effect. Therefore, peaks were ranked based on their combined measure of 
significance and direction of differential accessibility (-log10(FDR) ´ sign(log2(Fold 
Change))), resulting in a ranked list of peaks. The peaks that contained footprints were 
scanned for transcription factor binding motifs, resulting in transcription factor binding 
sites along the ranked peak list. In order to identify transcription factors with binding sites 
significantly enriched in differentially accessible peaks, a normalized enrichment score was 
calculated (as in gene set enrichment analysis (GSEA), (Subramanian et al., 2005)), and 
random sampling was performed on the ranked peak list to generate a null distribution and 
examine how probable it would be to obtain at least the observed enrichment by chance (p 
value) (Sergushichev, 2016). After multiple test correction, transcription factors were 
selected based on their FDR values (FDR < 0.05 cutoff) and they were ranked based on 
their normalized enrichment score. With this approach, approximately two dozen key 
transcription factors were identified for both the GM-CSF and memory contrasts. 
 
3.2.3.2 Identifying target nodes 
 
The next step in the directed network reconstruction was to select target nodes. Target 
nodes in this case are peaks, with a gene assigned to them. The selection criteria were that 
the peak has to (i) contain a footprint with a binding motif of the source node (transcription 
factor) and the peak has to be (ii) either differentially accessible and/or the gene assigned to 
it has to be differentially expressed. 
 
3.2.3.3 Node & network analysis 
 
Before investigating the functional impact of transcription factors (source nodes) based on 
the network structure, there are a few properties of the transcription factors (based on the 
data) that are worth considering, since they might be necessary for the transcription factors 
to play an important role. These are the relative abundance and differential expression of 
transcription factors. The notion is that the transcription factor might have to be present at 
  27 
least in a minimum quantity and it may (or may not) be important that it is differentially 
expressed in order to have a large impact in the network. Interestingly, the majority of the 
key transcription factors identified herein were not differentially expressed (although the 
exact fraction differed in case of the GM-CSF and Memory networks), meaning that even 
though they seem to be important regulators, they could not be identified by RNA-seq only 
on the basis of differential expression. The other characteristic to consider for key regulator 
candidates is their expression level, since they are less likely to be able to have an effect if 
they are very lowly expressed. For this purpose, the relative abundance was quantified by 
using the average of the logarithm of count per million reads across samples, and the 
distribution of expression level had a bimodal distribution, resulting in categories of 
“lowly” and “highly” expressed genes. Most of the identified key transcription factors were 
in the “highly” expressed category but not all. This information might be considered in 
downstream steps and, for example, for design of studies where transcription factors are 
followed-up. 
 
Next, the importance of transcription factors (source nodes) can be also evaluated based on 
the network structure. For this type of analysis there are several measures that can be 
computed for each node in the network, and they elucidate the role of the node in the 
network from a different aspect. Therefore, in several cases it might be a good idea to 
choose a set of measures suited for the type of network and question, compute these 
multiple measures, look at the agreement and disagreement between them, and draw 
conclusions from them together rather than considering only one type of measure. 
 
In this study, the networks in question were directed and for this type of networks one 
useful measure per node is the PageRank (Page et al., 1999). The intuitive interpretation of 
this measure is that a node is considered “important” (high PageRank value) if by starting 
on randomly chosen nodes of the network, and following the directed edges, there is a high 
chance of ending up on the given node. Since this rather focuses on the importance of nodes 
as targets, and at this step of this study the main purpose was to quantify the importance of 
transcription factors (source nodes), the PageRank of the network nodes was computed 
after inverting the directionality of all edges in the network (only for the purpose of this 
computation). After this computation, the nodes with high PageRank values (between the 
99th – 100th percentile of all node values from one network) were selected from both the 
GM-CSF and Memory network, and investigated across the two networks. This showed, 
that among the important transcription factors, there are three types based on whether they 
are important for the GM-CSF, Memory or both networks. This approach helped to narrow 
down and identify the set of transcription factors that might play an important role 
specifically in the molecular profile of GM-CSF cells. 
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To study the redundancy and synergy of transcription factors in the networks, their pairwise 
co-binding was quantified by computing the binary distance using the binding along peaks 
as binary vectors. This showed that there are clear groups (clusters) of transcriptions factors 
that act on largely shared genomic regions. Among these groups there were both examples 
for groups containing subtypes of the same or different transcription factor families. 
Furthermore, the target genes of individual or groups of transcription factors can be studied 
to look for enrichment of pathways among target genes. 
 
In summary, the above analysis, applying methodologies for data integration, network 
reconstruction and network analysis, allowed the identification of candidate genes for 
future follow-up studies with therapeutic aims. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Summary of results on the differentiation and ex vivo phenotype of human GM-CSF 
producing Thelper cells. The upper part summarizes the results on the induction, in vitro differentiation and 
cytokine profile of human GM-CSF producing Thelper cells. The lower part summarizes the results of the in-
depth characterization and analysis of the ex vivo phenotype of human GM-CSF producing Thelper cells. 
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4 CONCLUSIONS 
 
The research leading to this thesis was carried out with two aspects in mind, and the aim 
that these two aspects have a synergistic effect on each other: (i) addressing biological 
questions and at the same time (ii) explore the advantages of combining different 
experimental and computational methodologies. 
 
From a biological point of view, the thesis characterized the differentiation and molecular 
profile of Thelper cells that play a role in inflammatory diseases, and identified cytokines and 
transcription factors that might be particularly important players in these processes. 
 
From a methodological point of view, the thesis demonstrates that combining multiple 
approaches, data types and information allows one to gain insights into biological 
phenomena in a way that would otherwise not be possible. 
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